Genetic Studies of Early-onset Dementia
NCT04906863
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The aim of this study is to identify genetic factors that contribute to risk and progression of early-onset dementia (loss of memory function before the age of 70 years) across all ethnic groups, including Alzheimer's Disease, mild cognitive impairment and other dementias.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Dementia, Early Onset
- Alzheimer Dementia (AD)
- Mild Cognitive Impairment (MCI)
- Memory Loss
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 35 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Columbia University
- Last updated on ClinicalTrials.gov
- April 29, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
New York · 1
- Columbia University Irving Medical Center · New York, NY
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.